Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
暂无分享,去创建一个
S. Yusuf | Li-sheng Liu | P. Pais | Á. Avezum | J. Varigos | A. Budaj | S. Hawken | S. Ôunpuu | F. Lanas | L. Lisheng | T. Dans | M. McQueen
[1] J. Stockman,et al. Mortality in Relation to Smoking: 50 Years' Observations on Male British Doctors , 2006 .
[2] S. Yusuf,et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[3] F. Turnbull. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.
[4] M. Blaser,et al. Population attributable risks of esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.
[5] A. Iskandrian,et al. Major risk factors for cardiovascular disease: debunking the "only 50%" myth. , 2003, JAMA.
[6] N J Wald,et al. A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.
[7] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[8] I. Holme,et al. High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆ , 2002 .
[9] I. Holme,et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study , 2001, The Lancet.
[10] S. Yusuf,et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.
[11] S. Yusuf,et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.
[12] A. Negassa,et al. INTER-HEART: A global study of risk factors for acute myocardial infarction. , 2001, American heart journal.
[13] L. Wilhelmsen,et al. Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies. , 2001, European heart journal.
[14] J. Manson,et al. Primary prevention of coronary heart disease in women through diet and lifestyle. , 2000, The New England journal of medicine.
[15] A. Dyer,et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. , 1999, JAMA.
[16] M. de Lorgeril,et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. , 1999, Circulation.
[17] S. Johansson,et al. Coronary heart disease attack rate, incidence and mortality 1975-1994 in Göteborg, Sweden. , 1997, European heart journal.
[18] Salim Yusuf,et al. Risk factors for acute myocardial infarction in Indians: a case-control study , 1996, The Lancet.
[19] Alan D. Lopez,et al. The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .
[20] R. Collins,et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction : 14000 cases and 32000 controls in the United Kingdom , 1995 .
[21] R. Collins,et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. , 1995, BMJ.
[22] W. H. Hannon,et al. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. , 1994, Clinical chemistry.
[23] E. Barrett-Connor,et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. , 1991, JAMA.
[24] J Benichou,et al. Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. , 1990, Biometrics.
[25] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[26] D P Byar,et al. Estimating the population attributable risk for multiple risk factors using case-control data. , 1985, American journal of epidemiology.
[27] N. Breslow,et al. Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .
[28] N. Breslow,et al. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .
[29] R. Borth,et al. Quality control in clinical chemistry. Part 2. Assessment of analytical methods for routine use. , 1976 .
[30] S. Walter. The distribution of Levin's measure of attributable risk , 1975 .
[31] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .